Babu Kalpana, Padmapriya P G, Gowda Sunitha M N, Murthy Praveen R
Department of Uvea and Ocular Inflammation, Prabha Eye Clinic, Research Centre, Vittala International Institute of Ophthalmology, Bengaluru, India.
Department of Vitreoretinal Services, Prabha Eye Clinic, Research Centre, Vittala International Institute of Ophthalmology, Bengaluru, India.
Ocul Immunol Inflamm. 2025 Jan;33(1):166-171. doi: 10.1080/09273948.2024.2367654. Epub 2024 Jun 18.
To report a rare presentation of a proven case of infection presenting as multifocal choroiditis with recurrent choroidal neovascular membrane (CNVM) in one eye, initially misdiagnosed as punctate inner choroidopathy and later developed serpiginous-like choroiditis in the other eye.
Retrospective case report with a review of existing literature.
A 30-year-old women presented with metamorphopsia (OD) and best-corrected visual acuity (BCVA) of 6/24 (OD) and was diagnosed to have punctate inner choroidopathy with CNVM (OD). Since then, she had received four intravitreal anti-vascular endothelial growth factor injections over 3 years. Two years later, she developed a slowly progressing choroidal lesion radiating from the disc in a serpiginoid manner in the left eye. There was no vitritis. Labs revealed a positive QuantiFERON-TB Gold test. High-resolution computed tomography of the thorax showed sub-centimetre noncalcified lymph nodes in subcarinal and perivascular regions, minimal pleural thickening in left lower zone, minimal pericardial effusion, bronchiectatic changes, and fibrotic strands in right middle and left lower lobes. Bronchoalveolar lavage grew intracellularae (matrix-assisted laser desorption/ionization time-of-flight mass spectrometry). She was given a course of clarithromycin, moxifloxacin, rifampicin, and doxycycline for 12 months. Though the right eye remained stable, choroidal lesion in the left eye continued to progress threatening the fovea, requiring oral steroids, methotrexate, and an intravitreal dexamethasone implant. At the last follow-up, her BCVA was 6/18 (OD) and 6/6 (OS). Both eyes were stable.
This case highlights a rare presentation of proven infection presenting as multifocal choroiditis with recurrent CNVM in one eye and serpiginous-like choroiditis in the other eye, requiring aggressive treatment to salvage the vision.
报告一例经证实的罕见感染病例,表现为一只眼多灶性脉络膜炎伴复发性脉络膜新生血管膜(CNVM),最初被误诊为点状内层脉络膜病变,后来另一只眼发展为匐行性脉络膜炎。
回顾性病例报告并复习现有文献。
一名30岁女性出现视物变形(右眼),最佳矫正视力(BCVA)为6/24(右眼),被诊断为点状内层脉络膜病变伴CNVM(右眼)。此后,她在3年中接受了4次玻璃体内抗血管内皮生长因子注射。两年后,她左眼出现一个从视盘以匐行样方式缓慢进展的脉络膜病变。无玻璃体炎。实验室检查显示结核感染T细胞检测(QuantiFERON-TB Gold试验)呈阳性。胸部高分辨率计算机断层扫描显示隆突下和血管周围区域有小于1厘米的非钙化淋巴结,左下肺野有轻度胸膜增厚,有少量心包积液,有支气管扩张改变,右中叶和左下叶有纤维条索。支气管肺泡灌洗培养出细胞内分枝杆菌(基质辅助激光解吸/电离飞行时间质谱法)。她接受了为期12个月的克拉霉素、莫西沙星、利福平及多西环素治疗。尽管右眼保持稳定,但左眼的脉络膜病变继续进展,威胁到黄斑中心凹,需要口服类固醇、甲氨蝶呤及玻璃体内地塞米松植入物治疗。在最后一次随访时,她的BCVA为6/18(右眼)和6/6(左眼)。双眼均稳定。
本病例突出了一例经证实的罕见感染病例,表现为一只眼多灶性脉络膜炎伴复发性CNVM,另一只眼为匐行性脉络膜炎,需要积极治疗以挽救视力。